MCID: BNN001
MIFTS: 56

Bannayan-Riley-Ruvalcaba Syndrome malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Gastrointestinal diseases, Skin diseases, Fetal diseases, Cancer diseases

Aliases & Classifications for Bannayan-Riley-Ruvalcaba Syndrome

About this section

Aliases & Descriptions for Bannayan-Riley-Ruvalcaba Syndrome:

Name: Bannayan-Riley-Ruvalcaba Syndrome 49 10 11 45 22 23 12 51 67 65
Bannayan-Zonana Syndrome 10 45 22 23 47 67
Riley-Smith Syndrome 10 45 22 23 67
Ruvalcaba-Myhre-Smith Syndrome 10 22 23 67
Brrs 45 23 51 67
Bannayan-Ruvalcaba-Riley Syndrome 23 67 24
Bzs 45 23 67
Macrocephaly Multiple Lipomas and Hemangiomata 45 67
Pten Hamartoma Tumor Syndrome 67 65
 
Myhre-Riley-Smith Syndrome 23 51
Rmss 45 67
Macrocephaly Pseudopapilledema and Multiple Hemangiomata 67
Macrocephaly Pseudopapilledema and Multiple Hemangiomas 45
Macrocephaly, Multiple Lipomas, and Hemangiomata 22
Ruvalcaba -Myhre-Smith Syndrome 45
Ruvalcaba-Myhre Syndrome 23
Brr Syndrome 22
Phts 67

Characteristics:

Orphanet epidemiological data:

51
bannayan-riley-ruvalcaba syndrome:
Inheritance: Autosomal dominant; Age of onset: Infancy,Neonatal

HPO:

61
bannayan-riley-ruvalcaba syndrome:
Onset and clinical course: juvenile onset
Inheritance: autosomal dominant inheritance


Classifications:



External Ids:

OMIM49 153480
Disease Ontology10 DOID:0050657
Orphanet51 109
ICD10 via Orphanet28 Q87.8
UMLS via Orphanet66 C0265326
MedGen34 C0265326
MeSH36 D006223
UMLS65 C0265326, C1959582

Summaries for Bannayan-Riley-Ruvalcaba Syndrome

About this section
NIH Rare Diseases:45 Bannayan-riley-ruvalcaba syndrome (brrs) is one of the pten hamartoma tumor syndromes (phts), a spectrum of disorders caused by mutations in a gene called pten. brrs is a disorder present from birth that is characterized by macrocephaly (larger than normal sized head), intestinal polyposis (multiple benign polyps in the intestines), lipomas (tumors below the skin made up of fatty tissue), and pigmented skin lesion (macule) in the area of the penis called the glans penis. the symptoms of brrs vary from person to person. treatment is based on the symptoms present; however, because of the increased risk of developing cancer in people with the phts, increased cancer surveillance is recommended. last updated: 3/18/2013

MalaCards based summary: Bannayan-Riley-Ruvalcaba Syndrome, also known as bannayan-zonana syndrome, is related to cowden syndrome 1 and proteus syndrome, somatic, and has symptoms including intestinal polyposis, visceral angiomatosis and arteriovenous malformation. An important gene associated with Bannayan-Riley-Ruvalcaba Syndrome is PTEN (Phosphatase And Tensin Homolog), and among its related pathways are and Androgen receptor signaling pathway. Affiliated tissues include skin, thyroid and breast, and related mouse phenotypes are embryo and muscle.

Genetics Home Reference:23 Bannayan-Riley-Ruvalcaba syndrome is a genetic condition characterized by a large head size (macrocephaly), multiple noncancerous tumors and tumor-like growths called hamartomas, and dark freckles on the penis in males. The signs and symptoms of Bannayan-Riley-Ruvalcaba syndrome are present from birth or become apparent in early childhood.

OMIM:49 Blumenthal and Dennis (2008) provided a detailed review of PTEN-related tumor syndromes. (153480) more...

UniProtKB/Swiss-Prot:67 Bannayan-Riley-Ruvalcaba syndrome: A rare hamartomatous disorder characterized by macrocephaly and multiple hemangiomas as well as subcutaneous and visceral lipomas. It belongs to the family of hamartomatous polyposis syndromes that includes Peutz Jeghers syndrome, juvenile polyposis, and Cowden syndrome.

Related Diseases for Bannayan-Riley-Ruvalcaba Syndrome

About this section

Graphical network of the top 20 diseases related to Bannayan-Riley-Ruvalcaba Syndrome:



Diseases related to bannayan-riley-ruvalcaba syndrome

Symptoms for Bannayan-Riley-Ruvalcaba Syndrome

About this section

Symptoms by clinical synopsis from OMIM:

153480

Clinical features from OMIM:

153480

Symptoms:

 51 (show all 66)
  • macrocephaly/macrocrania/megalocephaly/megacephaly
  • hamartoma/tumefaction of the tongue/gingivae/oral mucosa
  • macules
  • abnormal pigmentary skin changes/skin pigmentation anomalies
  • capillary hemangioma/nevus/naevus flammeus/port-wine stain
  • cavernous/tuberous hemangioma
  • xanthomas/lipomas
  • polyposis of the bowel/colon/intestine
  • visceral angiomatosis (excluding skin)
  • arteriovenous malformations/vascular malformations (excluding port-wine stains)
  • penis anomalies
  • hypotonia
  • speech troubles/aphasia/dysphasia/echolalia/mutism/logorrhea/dysprosodia
  • neoplasms/tumors
  • autosomal dominant inheritance
  • pectus excavatum
  • scoliosis
  • gastrointestinal bleeding/hemorrhage/hematemesis/melena/rectorrhagia
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • hyperextensible joints/articular hyperlaxity
  • breast neoplasm/tumor/carcinoma/cancer
  • uterus/uterine/cervix/endometrium neoplasm/tumor/carcinoma/cancer
  • generalized obesity
  • dolichocephaly/scaphocephaly
  • frontal bossing/prominent forehead
  • downslanted palpebral fissures/anti-mongoloid slanting palpebral fissures
  • micrognathia/retrognathia/micrognathism/retrognathism
  • optic nerve anomaly/optic atrophy/anomaly of the papilla
  • visual loss/blindness/amblyopia
  • strabismus/squint
  • broad nose/nasal bridge
  • short/small nose
  • anteverted nares/nostrils
  • long philtrum
  • high vaulted/narrow palate
  • long/large ear
  • metacarpal anomalies/archibald's sign
  • broad/bifid thumb
  • cutis marmorata/marbled skin/livedo
  • acanthosis nigricans
  • cafe-au-lait spot
  • telangiectasiae of the skin
  • acute abdominal pain/colic
  • intestinal obstruction/ileus
  • aortic dilatation/dilation
  • angor pectoris/myocardial infarction
  • lymphedema
  • thyroiditis
  • hypoglycemia
  • motor deficit/trouble
  • seizures/epilepsy/absences/spasms/status epilepticus
  • autism/autistic disoders
  • myopathy
  • muscle weakness/flaccidity
  • dysostosis/chondrodysplasia/osteodysplasia/osteochondrosis/skeletal dysplasia
  • hemorrhage/hemorrhagic syndrome/excessive/long-lasting bleeding
  • intracranial/cerebral/meningeal hemorrhage
  • kidney/renal neoplasm/tumor/carcinoma/cancer
  • thyroid neoplasm/tumor/carcinoma/cancer
  • cortical adrenal neoplasm/tumor/carcinoma/cancer
  • central nervous system/peripheral nerves neoplasm/tumor/carcinoma/cancer
  • meningioma
  • wasted (excluding lipodystrophy)/poorly muscled build/cachexy
  • tall stature/gigantism/growth acceleration
  • short stature/dwarfism/nanism
  • early death/lethality

HPO human phenotypes related to Bannayan-Riley-Ruvalcaba Syndrome:

(show all 92)
id Description Frequency HPO Source Accession
1 intestinal polyposis hallmark (90%) HP:0200008
2 visceral angiomatosis hallmark (90%) HP:0100761
3 arteriovenous malformation hallmark (90%) HP:0100026
4 neurological speech impairment hallmark (90%) HP:0002167
5 muscular hypotonia hallmark (90%) HP:0001252
6 cavernous hemangioma hallmark (90%) HP:0001048
7 hypermelanotic macule hallmark (90%) HP:0001034
8 multiple lipomas hallmark (90%) HP:0001012
9 macrocephaly hallmark (90%) HP:0000256
10 abnormality of the penis hallmark (90%) HP:0000036
11 cognitive impairment typical (50%) HP:0100543
12 neoplasm of the breast typical (50%) HP:0100013
13 uterine neoplasm typical (50%) HP:0010784
14 scoliosis typical (50%) HP:0002650
15 gastrointestinal hemorrhage typical (50%) HP:0002239
16 obesity typical (50%) HP:0001513
17 joint hypermobility typical (50%) HP:0001382
18 pectus excavatum typical (50%) HP:0000767
19 thyroiditis occasional (7.5%) HP:0100646
20 neoplasm of the adrenal cortex occasional (7.5%) HP:0100641
21 telangiectasia of the skin occasional (7.5%) HP:0100585
22 neoplasm of the thyroid gland occasional (7.5%) HP:0100031
23 renal neoplasm occasional (7.5%) HP:0009726
24 abnormality of thumb phalanx occasional (7.5%) HP:0009602
25 intestinal obstruction occasional (7.5%) HP:0005214
26 decreased body weight occasional (7.5%) HP:0004325
27 short stature occasional (7.5%) HP:0004322
28 myopathy occasional (7.5%) HP:0003198
29 short nose occasional (7.5%) HP:0003196
30 meningioma occasional (7.5%) HP:0002858
31 skeletal dysplasia occasional (7.5%) HP:0002652
32 intracranial hemorrhage occasional (7.5%) HP:0002170
33 abdominal pain occasional (7.5%) HP:0002027
34 frontal bossing occasional (7.5%) HP:0002007
35 hypoglycemia occasional (7.5%) HP:0001943
36 abnormality of coagulation occasional (7.5%) HP:0001928
37 aortic dilatation occasional (7.5%) HP:0001724
38 coronary artery disease occasional (7.5%) HP:0001677
39 muscle weakness occasional (7.5%) HP:0001324
40 seizures occasional (7.5%) HP:0001250
41 abnormality of the metacarpal bones occasional (7.5%) HP:0001163
42 lymphedema occasional (7.5%) HP:0001004
43 cutis marmorata occasional (7.5%) HP:0000965
44 cafe-au-lait spot occasional (7.5%) HP:0000957
45 acanthosis nigricans occasional (7.5%) HP:0000956
46 autism occasional (7.5%) HP:0000717
47 optic atrophy occasional (7.5%) HP:0000648
48 visual impairment occasional (7.5%) HP:0000505
49 downslanted palpebral fissures occasional (7.5%) HP:0000494
50 strabismus occasional (7.5%) HP:0000486
51 anteverted nares occasional (7.5%) HP:0000463
52 macrotia occasional (7.5%) HP:0000400
53 micrognathia occasional (7.5%) HP:0000347
54 long philtrum occasional (7.5%) HP:0000343
55 dolichocephaly occasional (7.5%) HP:0000268
56 abnormality of the palate occasional (7.5%) HP:0000174
57 tall stature occasional (7.5%) HP:0000098
58 lipoma HP:0012032
59 postnatal growth retardation HP:0008897
60 abnormally prominent line of schwalbe HP:0007873
61 thick corpus callosum HP:0007074
62 hamartomatous polyposis HP:0004390
63 macrodactyly HP:0004099
64 birth length greater than 97th percentile HP:0003517
65 myopathy HP:0003198
66 meningioma HP:0002858
67 scoliosis HP:0002650
68 intussusception HP:0002576
69 hematochezia HP:0002573
70 supernumerary nipple HP:0002558
71 delayed gross motor development HP:0002194
72 frontal bossing HP:0002007
73 hypoglycemia HP:0001943
74 joint hypermobility HP:0001382
75 muscular hypotonia HP:0001252
76 seizures HP:0001250
77 intellectual disability HP:0001249
78 hemangioma HP:0001028
79 angiokeratoma HP:0001014
80 multiple lipomas HP:0001012
81 cafe-au-lait spot HP:0000957
82 acanthosis nigricans HP:0000956
83 hashimoto thyroiditis HP:0000872
84 pectus excavatum HP:0000767
85 delayed speech and language development HP:0000750
86 amblyopia HP:0000646
87 pseudopapilledema HP:0000538
88 downslanted palpebral fissures HP:0000494
89 strabismus HP:0000486
90 macrocephaly HP:0000256
91 high palate HP:0000218
92 long penis HP:0000040

Drugs & Therapeutics for Bannayan-Riley-Ruvalcaba Syndrome

About this section

Interventional clinical trials:

Search ClinicalTrials, NIH Clinical Center for Bannayan-Riley-Ruvalcaba Syndrome

Genetic Tests for Bannayan-Riley-Ruvalcaba Syndrome

About this section

Genetic tests related to Bannayan-Riley-Ruvalcaba Syndrome:

id Genetic test Affiliating Genes
1 Bannayan-Riley-Ruvalcaba Syndrome22 PTEN

Anatomical Context for Bannayan-Riley-Ruvalcaba Syndrome

About this section

MalaCards organs/tissues related to Bannayan-Riley-Ruvalcaba Syndrome:

33
Skin, Thyroid, Breast, Cervix, Uterus, Tongue, Cortex

Animal Models for Bannayan-Riley-Ruvalcaba Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Bannayan-Riley-Ruvalcaba Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053808.4BMPR1A, HADHA, PTEN, SMAD4
2MP:00053698.2BMPR1A, HADHA, PTEN, SMAD4

Publications for Bannayan-Riley-Ruvalcaba Syndrome

About this section

Articles related to Bannayan-Riley-Ruvalcaba Syndrome:

(show all 47)
idTitleAuthorsYear
1
Identification of Deleterious SNPs and Their Effects on Structural Level in CHRNA3 Gene. (26002565)
2015
2
International Biological Engagement Programs Facilitate Newcastle Disease Epidemiological Studies. (26539424)
2015
3
Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls. (25265166)
2014
4
Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE. (23229638)
2013
5
Intracranial hypertension presenting with severe visual failure, without concurrent headache, in a child with nephrotic syndrome. (24112785)
2013
6
Hypopituitarism as the presenting feature of bronchogenic carcinoma with metastases to the pituitary gland. (23776875)
2013
7
Intravascular ultrasound and fractional flow reserve in assessment of the intermediate coronary stenosis: what you see is not what you get. (23352779)
2013
8
Progesterone utilizes the PI3K-AKT pathway in human spermatozoa to regulate motility and hyperactivation but not acrosome reaction. (23623968)
2013
9
Norrie disease: first mutation report and prenatal diagnosis in an Indian family. (22674248)
2012
10
Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor. (22850893)
2012
11
Suppression of homeobox transcription factor VentX promotes expansion of human hematopoietic stem/multipotent progenitor cells. (22791709)
2012
12
Substrate specificity and inhibition of human kallikrein-related peptidase 3 (KLK3 or PSA) activated with sodium citrate and glycosaminoglycans. (20371359)
2010
13
Gq protein mediates UVB-induced cyclooxygenase-2 expression by stimulating HB-EGF secretion from HaCaT human keratinocytes. (20117092)
2010
14
Moderate acute cholecystitis: to cut now or to cut later. (20002938)
2009
15
Effect of polycythemia on hypoxia induced pulmonary hypertension and pulmonary vascular remodeling in rats]. (19764557)
2009
16
Haptoglobin, serum amyloid-a and ceruloplasmin concentrations in goats with mixed helminth infection]. (18985576)
2008
17
Regulatory mechanism of Bcl-2 in uterine leiomyomas. (19205434)
2008
18
Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor. (18289674)
2008
19
Distribution of galanin receptor-2 immunoreactive neurones in the ovine hypothalamus: no evidence for involvement in the control of gonadotrophin-releasing hormone secretion. (18001326)
2007
20
PYY and the pancreas: inhibition of tumor growth and inflammation. (17194501)
2007
21
Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women. (17998028)
2007
22
Permanent atrial fibrillation ablation surgery in CABG and aortic valve patients is at least as effective as in mitral valve disease. (16541348)
2006
23
Anesthesia for radical prostatectomy. (16673607)
2005
24
Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. (14965365)
2004
25
A single amino acid change (E85K) in human PCNA that leads, relative to wild type, to enhanced DNA synthesis by DNA polymerase delta past nucleotide base lesions (TLS) as well as on unmodified templates. (15595847)
2004
26
Embryonal rhabdomyosarcoma of the orbit in a liver transplant recipient. (12819877)
2003
27
Analysis of CHK2 in patients with myelodysplastic syndromes. (12363465)
2002
28
Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis. (11753040)
2002
29
Genomic organization of the JEM-1 (BLZF1) gene on human chromosome 1q24: molecular cloning and analysis of its promoter region. (11056056)
2000
30
Meningococcal infection in pilgrims returning from the Haj. (10769945)
2000
31
Black intraocular lens for leukocoria. (11008059)
2000
32
Paraneoplastic thrombocytosis-induced systemic thromboembolism in a cat. (10580907)
1999
33
Chronology of labyrinthitis ossificans induced by Streptococcus pneumoniae meningitis. (10369285)
1999
34
The binding site for UCH-L3 on ubiquitin: mutagenesis and NMR studies on the complex between ubiquitin and UCH-L3. (10518943)
1999
35
Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells. (9679970)
1998
36
Differential expression of human metallothionein isoform I mRNA in human proximal tubule cells exposed to metals. (9831543)
1998
37
Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons. (9736634)
1998
38
Renpenning syndrome maps to Xp11. (9545405)
1998
39
A Scottish family with Bazex-DuprAc-Christol syndrome: follicular atrophoderma, congenital hypotrichosis, and basal cell carcinoma. (8782050)
1996
40
Identification of a functional thyroid hormone response element in the upstream flanking region of the human Na,K-ATPase beta 1 gene. (8392703)
1993
41
Congenital heart block in one of the HLA identical twins. (8282145)
1993
42
Effects of site-directed mutagenesis at residues cysteine-31 and cysteine-184 on lecithin-cholesterol acyltransferase activity. (1848009)
1991
43
Recombinant human beta-nerve growth factor (NGF): biological activity and properties in an enzyme immunoassay. (2079723)
1990
44
Clinical study of 9 familial atrial fibrillation cases. (6414778)
1983
45
Thyrotropin, total thyroxine, thyroxine binding capacity and free thyroxine index in patients with gonadal dysgenesis (karyotype 45/XO). (6181987)
1982
46
Encephalomalacia simulating the clinical and radiological aspects of brain tumor; a report of 6 cases. (13346403)
1956
47

Variations for Bannayan-Riley-Ruvalcaba Syndrome

About this section

UniProtKB/Swiss-Prot genetic disease variations for Bannayan-Riley-Ruvalcaba Syndrome:

67
id Symbol AA change Variation ID SNP ID
1PTENp.Tyr68HisVAR_007462
2PTENp.Ser170ArgVAR_007470
3PTENp.Ala34AspVAR_008734
4PTENp.Cys105TyrVAR_008735
5PTENp.Ile135ValVAR_008736
6PTENp.Pro246LeuVAR_008740
7PTENp.Cys105PheVAR_026256
8PTENp.Asp107TyrVAR_026257

Clinvar genetic disease variations for Bannayan-Riley-Ruvalcaba Syndrome:

5 (show all 20)
id Gene Variation Type Significance SNP ID Assembly Location
1PTENNM_000314.6(PTEN): c.338G> T (p.Ser113Ile)single nucleotide variantPathogenicrs587781254GRCh37Chr 10, 89692854: 89692854
2PTENNM_000314.6(PTEN): c.379G> A (p.Gly127Arg)single nucleotide variantPathogenicrs587781255GRCh37Chr 10, 89692895: 89692895
3PTENNM_000314.6(PTEN): c.781C> T (p.Gln261Ter)single nucleotide variantPathogenicrs730882131GRCh38Chr 10, 87957999: 87957999
4PTENNM_000314.6(PTEN): c.49C> T (p.Gln17Ter)single nucleotide variantPathogenicrs786204910GRCh37Chr 10, 89624275: 89624275
5PTENNM_000314.6(PTEN): c.437T> G (p.Leu146Ter)single nucleotide variantPathogenicrs786204933GRCh38Chr 10, 87933196: 87933196
6PTENNM_000314.6(PTEN): c.860C> G (p.Ser287Ter)single nucleotide variantLikely pathogenicrs863224909GRCh37Chr 10, 89720709: 89720709
7PTENNM_000314.6(PTEN): c.987_996dupTAAAGACAAA (p.Ala333Terfs)duplicationPathogenicrs864622387GRCh38Chr 10, 87961079: 87961088
8PTENNM_000314.6(PTEN): c.845delG (p.Gly282Aspfs)deletionPathogenicrs864622451GRCh38Chr 10, 87960937: 87960937
9PTENNM_000314.6(PTEN): c.697C> T (p.Arg233Ter)single nucleotide variantPathogenicrs121909219GRCh37Chr 10, 89717672: 89717672
10PTENNM_000314.6(PTEN): c.510T> A (p.Ser170Arg)single nucleotide variantPathogenicrs121909221GRCh37Chr 10, 89711892: 89711892
11PTENNM_000314.6(PTEN): c.388C> T (p.Arg130Ter)single nucleotide variantPathogenicrs121909224GRCh37Chr 10, 89692904: 89692904
12PTENNM_000314.6(PTEN): c.586delC (p.His196Thrfs)deletionPathogenicrs587776670GRCh37Chr 10, 89711968: 89711968
13PTENNM_000314.6(PTEN): c.534_535delTAinsAT (p.Tyr178Ter)indelPathogenicrs397515374GRCh37Chr 10, 89711916: 89711917
14PTENNM_000314.6(PTEN): c.640C> T (p.Gln214Ter)single nucleotide variantPathogenicrs121909227GRCh37Chr 10, 89717615: 89717615
15PTENNM_000314.6(PTEN): c.766G> T (p.Glu256Ter)single nucleotide variantPathogenicrs121909228GRCh37Chr 10, 89717741: 89717741
16PTENNM_000314.6(PTEN): c.389G> A (p.Arg130Gln)single nucleotide variantPathogenicrs121909229GRCh37Chr 10, 89692905: 89692905
17PTENNM_000314.6(PTEN): c.1003C> T (p.Arg335Ter)single nucleotide variantPathogenicrs121909231GRCh37Chr 10, 89720852: 89720852
18PTENNM_000314.6(PTEN): c.507delC (p.Ser170Valfs)deletionPathogenicrs587776673GRCh37Chr 10, 89711889: 89711889
19PTENPTEN, DELdeletionPathogenic
20PTENNM_000314.6(PTEN): c.395G> T (p.Gly132Val)single nucleotide variantPathogenicrs121909241GRCh37Chr 10, 89692911: 89692911

Expression for genes affiliated with Bannayan-Riley-Ruvalcaba Syndrome

About this section
Search GEO for disease gene expression data for Bannayan-Riley-Ruvalcaba Syndrome.

Pathways for genes affiliated with Bannayan-Riley-Ruvalcaba Syndrome

About this section

GO Terms for genes affiliated with Bannayan-Riley-Ruvalcaba Syndrome

About this section

Biological processes related to Bannayan-Riley-Ruvalcaba Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein dephosphorylationGO:00064709.6CDKN3, PTEN
2embryonic digit morphogenesisGO:00427339.3BMPR1A, SMAD4
3peptidyl-tyrosine dephosphorylationGO:00353359.3CDKN3, PTEN
4BMP signaling pathwayGO:00305099.3BMPR1A, SMAD4
5cellular response to BMP stimulusGO:00717739.3BMPR1A, SMAD4
6palate developmentGO:00600219.1BMPR1A, SMAD4

Molecular functions related to Bannayan-Riley-Ruvalcaba Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1phosphatase activityGO:00167919.5CDKN3, MINPP1

Sources for Bannayan-Riley-Ruvalcaba Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet